Content area
Full Text
Between them, they did what conventional wisdom had said couldn't be done: Carl C. Peck, M.D., and Gerald F. Meyer converted an FDA bureaucracy that had long been seen as "broken" to one that most would now agree works well. When they step down in the next seven months from their respective positions as director and deputy director of FDA's enter for Drug Evaluation and Research, a remarkable era of change will have closed. Peck, who came to FDA in 1987 from he Uniformed Services University of the Health Sciences, will retire November 1 to accept an appointment as Research Professor of Clinical Drug Research at Leiden University in The Netherlands. Meyer retires in January after 22 years with FDA and 33 in the federal government.
Pharmaceutical Manufacturers Association president Gerald S. Mossinghoff said: "The team of Dr. Carl Peck,...